Corcept Therapeutics

Corcept Therapeutics Financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Corcept Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$35.7

2024-09-12

Market Capitalization

$3.7 B

2024-09-12

Revenue

$482.4 M

FY, 2023

CreditSafe Score

Score changed on Oct 03, 2024

Premium Content only available in Craft’s Intelligence Portal

View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.

Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.

Learn more

Financial Statements

USD	FY, 2011	FY, 2012	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017	FY, 2018	FY, 2019	FY, 2020	FY, 2021	FY, 2022	FY, 2023
Revenue		3.3M	10.4M	26.6M	50.3M	81.3M	159.2M	251.2M	306.5M	353.9M	366.0M	401.9M	482.4M
Revenue growth, %				156.4%	89.4%	61.7%
Cost of goods sold		91.0K	143.0K	882.0K	1.4M	2.1M	3.6M	5.2M	5.5M	5.6M	5.3M	5.4M	6.5M
Gross profit		3.2M	10.2M	25.7M	48.9M	79.3M	155.6M	246.0M	301.0M	348.3M		396.5M	475.9M
Gross profit margin, %		97.2%	98.6%	96.7%	97.3%	97.5%	97.8%	97.9%	98.2%	98.4%		98.7%	98.7%
General and administrative expense	11.3M	25.4M	31.2M	34.9M	36.9M	45.2M	62.4M	81.3M	100.4M	105.3M	122.4M	152.8M	184.3M
Operating expense total	32.3M	39.5M	31.2M	34.9M	52.4M	69.1M	102.8M	156.5M	189.4M	220.1M	236.2M	283.8M	368.6M
EBIT	(32.3M)	(36.3M)	(41.5M)	(27.6M)	(3.4M)	10.2M	52.9M	89.5M	111.6M	128.2M	124.5M	112.6M	107.3M
EBIT margin, %		-1096.8%	-400.7%	-104.0%	-6.8%	12.5%	33.2%	35.6%	36.4%	36.2%		28.0%	22.2%
Interest income	3.0K
Interest expense		1.7M	4.5M	3.8M		2.0M
Pre tax profit							52.8M	92.2M	116.7M	131.6M	125.0M	116.2M	124.6M
Income tax expense							(76.3M)	16.7M	22.5M	25.6M	12.5M	14.8M	18.4M
Net Income	(32.4M)	(38.0M)	(46.0M)	(31.4M)	(6.4M)	8.1M	129.1M	75.4M	94.2M	106.0M	112.5M	101.4M	106.1M
EPS												0.9	0.9

Corcept Therapeutics Financials

CreditSafe Score

Financial Statements

Footer menu

Product

Solutions

Resources

Company